Using serum transforming growth factor-β to predict myocardial fibrosis

Circulation Research

Volumn 106, Issue 4, 2010, Pages

  Sovari, Ali A ^a   Dudley, Samuel C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROBLAST; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; LETTER; MYOFIBROBLAST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH;

BIOLOGICAL MARKERS; FIBROBLASTS; FIBROSIS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 77949367828     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.215921     Document Type: Letter

References (5)

1. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell. Circ Res. 2009;105:1164-1176.
2. Sovari AA, Morita N, Weiss JN, Karagueuzian HS. Serum transforming growth factor-beta1 as a risk stratifier of sudden cardiac death. Med Hypotheses. 2008;71:262-265.
3. Squires CE, Escobar GP, Payne JF, Leonardi RA, Goshorn DK, Sheats NJ, Mains IM, Mingoia JT, Flack EC, Lindsey ML. Altered fibroblast function following myocardial infarction. J Mol Cell Cardiol. 2005;39:699-707.
4. Sigel AV, Centrella M, Eghbali-Webb M. Regulation of proliferative response of cardiac fibroblasts by transforming growth factor-beta 1. J Mol Cell Cardiol. 1996;28:1921-1929.
5. Pepper MS. Transforming growth factor-beta: vasculogenesis, angio-genesis, and vessel wall integrity. Cytokine Growth Factor Rev. 1997;8: 21-43.